Current Report Filing (8-k)
08 April 2020 - 6:16AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
April 7, 2020
|
BiomX Inc.
|
|
|
(Exact Name of Registrant as Specified in its Charter)
|
|
Delaware
|
|
0001-38762
|
|
82-3364020
|
(State or other jurisdiction
of incorporation)
|
|
(Commission File Number)
|
|
(I.R.S. Employer
Identification No.)
|
7 Pinhas Sapir St., Floor 2
Ness Ziona, Israel
|
|
7414002
|
(Address of Principal Executive Offices)
|
|
(Zip Code)
|
Registrant’s telephone number, including
area code: +972 723942377
|
n/a
|
|
|
(Former name or former address, if changed since last report)
|
|
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities registered pursuant to Section
12(b) of the Act:
Title of each class
|
|
Trading Symbol(s)
|
|
Name of each exchange on which registered
|
Units, each consisting of one share of Common Stock, $0.0001 par value, and one Warrant entitling the holder to receive one half share of Common Stock
|
|
PHGE.U
|
|
NYSE American
|
Shares of Common Stock, $0.0001 par value, included as part of the Units
|
|
PHGE
|
|
NYSE American
|
Warrants included as part of the Units
|
|
PHGE.WS
|
|
NYSE American
|
Indicate by check mark whether the registrant is an emerging
growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☒
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 8.01 Other Events.
On March 31, 2020, BiomX Inc. (the “Company”)
issued a press release announcing that it will hold its 2020 Annual Meeting of Stockholders (the “2020 Annual Meeting”)
on June 3, 2020 at 9:00 a.m. Eastern Time. In light of public health concerns regarding the COVID-19 pandemic, the Annual Meeting
will be held solely by remote communication, in a virtual-only format.
Stockholders of record of the Company’s
common stock at the close of business on April 17, 2020 are entitled to notice of, and to vote during, the 2020 Annual Meeting.
The Company expects the notice of the 2020 Annual Meeting, definitive proxy statement and Notice of Internet Availability of Proxy
Materials (collectively, the “proxy materials”) will be mailed to stockholders on or about April 21, 2020.
Because the 2020 Annual Meeting is the Company’s
first annual meeting of stockholders, the Company has established a deadline for the receipt of stockholder proposals submitted
pursuant to Rule 14a-8 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), for inclusion in the
Company’s proxy materials for the 2020 Annual Meeting. In order to be considered for inclusion, such proposals must be received
in writing by the Company before the close of business on [April 17, 2020] and must also comply with the applicable requirements
of Rule 14a-8 of the Exchange Act. The [April 17, 2020] deadline will also apply in determining whether notice of a stockholder
proposal is timely for purposes of exercising discretionary voting authority with respect to proxies under Rule 14a-4(c)(1) of
the Exchange Act.
Additionally, in accordance with the advanced
notice provisions of the Company’s Bylaws, the Company has set deadlines for a stockholder to properly bring nominations
of directors or any other business before the 2020 Annual Meeting. The Bylaws provide that if less than 90 calendar days’
notice of the meeting is given to stockholders, director nominations must be mailed or delivered to the Company not later than
the close of business on the seventh calendar day following the date notice of the meeting is mailed, or 5:00 p.m. Eastern Time
on April 28, 2020. The Bylaws also provide that in the event that less than 45 calendar days’ prior public disclosure of
the date of the annual meeting is made to stockholders, notice of other business to be brought before the meeting must be received
not later than the close of business on the tenth business day following the date of the public disclosure, or 5:00 p.m. Eastern
Time on April 21, 2020.
Any stockholder proposal for inclusion in
the Company’s proxy materials, notice of proposed business to be brought before the 2020 Annual Meeting, or director nomination
should be sent to the Company at 7 Pinhas Sapir St., Floor 2, Ness Ziona, Israel 7414002, Attention: Corporate Secretary.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
SIGNATURE
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
BIOMX INC.
|
|
|
|
April 7, 2020
|
By:
|
/s/ Jonathan Solomon
|
|
|
Name: Jonathan Solomon
|
|
|
Title: Chief Executive Officer
|
2
BiomX (AMEX:PHGE.U)
Historical Stock Chart
From Nov 2024 to Dec 2024
BiomX (AMEX:PHGE.U)
Historical Stock Chart
From Dec 2023 to Dec 2024
Real-Time news about BiomX Inc (American Stock Exchange): 0 recent articles
More Biomx Inc. News Articles